Skip to main content

Featured

The Historical Significance of Good Friday

Good Friday is one of the most solemn days in Christianity, commemorating the crucifixion of Jesus Christ. Observed on the Friday before Easter Sunday, it marks the culmination of Holy Week and serves as a day of reflection, mourning, and reverence. Historically, Good Friday traces back to the early Christian church, when believers honored Jesus' sacrifice for humanity. According to biblical accounts, Jesus was arrested, tried, and sentenced to death by crucifixion under the Roman governor Pontius Pilate. His execution, believed to have occurred around A.D. 30, is seen as the ultimate act of redemption, paving the way for salvation in Christian theology. The name "Good Friday" may seem paradoxical, given the suffering endured by Jesus. However, the term "good" in this context is understood to mean "holy" or "pious," signifying the sacred nature of the day. Across the world, Christians observe Good Friday through fasting, prayer, and special c...

article

Controversial Turkish Import Endangers Newborns in Alberta, Documents Reveal

 

Recent documents have raised alarming concerns over Alberta’s emergency importation of children’s pain medication from Turkey. Produced by Atabay Pharmaceuticals and sold under the brand name Parol Suspension, the drug is marketed at a concentration of 24 mg/ml—significantly lower than the 32 mg/ml concentration found in the standard, Canadian-authorized formulation.

Health experts and opposition critics warn that this altered concentration poses a twofold risk. First, the discrepancy could lead to dosing errors if parents and caregivers, accustomed to the standard formulation, misjudge the correct volume needed. Second, there are fears that the lower concentration may lead to the clogging of hospital feeding tubes—a critical concern for vulnerable newborns.

Alberta Blue Cross has informed pharmacists that Parol must be dispensed with enhanced caution, requiring additional education on its proper use. Critics argue that the rushed procurement—amounting to approximately $80 million—exemplifies a misstep in prioritizing political expedience over stringent safety protocols. With traditional supplies of children’s pain medications already in short supply, many worry that this controversial alternative might jeopardize the health of Alberta’s youngest patients.

Further review and tighter regulatory oversight are now being called for, as stakeholders demand that the province safeguard the well-being of newborns and ensure that emergency measures do not compromise pediatric care.

Comments